MDB Capital Holdings (MDBH) Q2 FY26 earnings call

MDB Capital Holdings is navigating a challenging microcap market by strategically focusing on monetizing its four core assets: Public Ventures, PatentVest, eXoZymes, and Paulex Bio. The firm is pivoting to a leaner operating model, targeting $5 million to $6 million in annual operational expenses, to protect against dilution and maximize shareholder leverage. While new company launches are temporarily slowed, MDB is actively pursuing partnerships, spin-outs, and commercialization efforts for its existing portfolio, aiming for key value inflection points in the near term.